BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1197 related articles for article (PubMed ID: 18093814)

  • 41. Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
    Peterson M; Beck S; Bihrle R; Einhorn L; Foster R
    BJU Int; 2009 Jul; 104(2):176-8. PubMed ID: 19493258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Fujisawa M
    Int J Urol; 2010 Oct; 17(10):881-5. PubMed ID: 20731738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Retroperitoneal lymph node dissection for patients with advanced testicular tumor].
    Takasaki N; Ueda H; Isurugi K
    Hinyokika Kiyo; 1994 Oct; 40(10):957-61. PubMed ID: 7992714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Orchidectomy after primary chemotherapy for metastatic testicular cancer.
    Ramsey S; Kerr G; Howard GC; Donat R
    Urol Int; 2013; 91(4):439-44. PubMed ID: 24021555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experiences in the treatment of advanced nonseminomatous testicular tumor].
    Scheiber K; Salzer M; Bartsch G
    Wien Klin Wochenschr; 1986 Aug; 98(15):481-6. PubMed ID: 2429460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Management of advanced seminoma: retrospective study of 96 patients].
    Bompas E; Fléchon A; Biron P; Droz JP
    Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A case of testicular cancer in which complete response was achieved with chemotherapy including cisplatin, etoposide and bleomycin, and salvage surgery].
    Uekado Y; Matsumoto M; Inagaki T; Shintani Y
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):543-6. PubMed ID: 7510465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
    Vaughn DJ
    Urol Clin North Am; 2007 May; 34(2):171-7; abstract viii-ix. PubMed ID: 17484922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Advanced germinal tumors of the testicle: clinical experience with cisplatin, bleomycin and vinblastine (PVB) or etoposide (BEP)].
    Alonso Curbera G; González-Manzano R; Aramendía Beitia JM; Martínez Monge R; Agüera Fernández L; Rebollo Liceaga J
    Rev Med Univ Navarra; 1993; 38(1):13-8. PubMed ID: 8711305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The role of salvage surgery following chemotherapy in advanced testicular cancer].
    Miki T; Saki S; Kotake T
    Hinyokika Kiyo; 1994 Oct; 40(10):951-5. PubMed ID: 7992713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Carboplatin-etoposide-bleomycine chemotherapy protocol in the treatment of patients with metastatic non-seminomatous germ-cell testicular tumours with good prognosis].
    Jeremić B; Djurić Lj; Djordjević S; Cirović V; Milojević Lj; Stanisavljević B; Matović M; Mijatović Lj
    Srp Arh Celok Lek; 1994; 122(9-10):257-9. PubMed ID: 17977429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Metachronous testicular tumor of an extragonadal germ cell tumor].
    Häcker A; Hatzinger M; Knoll T; Michel MS; Köhrmann KU; Alken P; Siegsmund M
    Aktuelle Urol; 2003 Oct; 34(6):413-5. PubMed ID: 14579191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retroperitoneal lymph node dissection after chemotherapy.
    Winter C; Raman JD; Sheinfeld J; Albers P
    BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
    Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wait-and-see policy in clinical stage I non-seminomatous germ cell tumors of the testis.
    Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Marrink J; de Bruijn HW; Oldhoff J
    Eur J Surg Oncol; 1986 Sep; 12(3):283-7. PubMed ID: 3019779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
    Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
    J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    Marwaha S; Venner PM; North SA
    Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
    Bokemeyer C; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Einhorn L; Nichols CR; Hartmann JT
    Cancer; 2001 Apr; 91(7):1394-401. PubMed ID: 11283942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.